PeptidePedia The community reference

Adverse effects of GLP-1 receptor agonists: difference between revisions

Diff·revision 33 → 34·14:30, 26 Nov 2025

Difference between revision 33 and revision 34 of Adverse effects of GLP-1 receptor agonists. This revision changed no lines of source — the edit was a null or whitespace change.

Revision 33 — 18:53, 3 Nov 2025
RegainRomilly (talk)
rm the comparison with a compound that has no comparable safety dataset
5,791 bytes ±0
Revision 34 — 14:30, 26 Nov 2025
BUD_Bertram (talk)
add the placebo rate next to the treatment rate
5,791 bytes ±0
No change to the page source.